Regulatory News
Thursday, December 1, 2016
BRIEF-Pfizer's pain drug Lyrica meets goal in late-stage pediatric epilepsy study
* lyrica (pregabalin) phase 3 trial in pediatric epilepsy
meets primary endpoint
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment